Increased intakes of omega-3 fatty acids may improve sleep quality
A new study from the UK suggests higher blood levels of docosahexaenoic acid seem to be associated with less bedtime resistance and total sleep disturbance in children.
The Brazilian Academy of Neurology has released new guidelines and recommendations for neurologists to use vitamin D in multiple sclerosis patients.
Based on the latest research in vitamin D and multiple sclerosis (MS), the Scientific Department of Neuro- immunology (DCNI) of the Brazilian Academy of Neurology (ABN) has established a set of guidelines on the use of vitamin D supplements for neurologists who care for people with MS (1). Their recommendations and guidelines are as follows:
MS is an autoimmune disease in which the own immune system attacks the nerves in the brain and spinal cord. This can lead to various symptoms all over the body including difficulties walking, talking, swallowing and thinking. Past research has shown that people with low vitamin D levels are most likely to develop MS later in life (2). Researchers have also found that MS is more prevalent in places farther from the equator, where there is much less UVB radiation, which induces vitamin D production in skin.